ASX ANNOUNCEMENT Brisbane, 1st May, 2017 ADMEDUS HSV-2 PHASE IIa RESULTS WEBINAR • Admedus investor webinar Thursday, 4 May 2017 • 9am AEST Sydney/Melbourne/Brisbane time; 7am AWST Perth time Admedus Limited (ASX:AHZ) today announced that it will hold an investor webinar on Thursday, 4 May 2017 to present the results of the HSV-2 Phase IIa program and provide a business overview on the rest of its immunotherapies programs including the HPV treatment program and its work in the area of RNA vaccines. The webinar details Date: 4 May, 2017 Time: 9am Australian Eastern Standard Time (AEST); 7am Australian Western Standard Time (ASWT) Please register to attend the webinar at: https://attendee.gotowebinar.com/register/2780413500734718467 Follow us: Twitter: @Admedus Facebook: www.facebook.com/pages/Admedus Website: www.admedus.com
Ann: HSV-2 Phase IIa Results Investor Webinar, page-2
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |